Navigation Links
Roche Offers Innovative Website Designed to Empower Cancer Patients
Date:10/31/2007

-Interactive Online Resource Provides Customized Oral Chemotherapy

Information-

NUTLEY, N.J., Oct. 31 /PRNewswire/ -- Maximizing on the momentum gained during Breast Cancer Awareness Month, healthcare providers and advocacy organizations now have a helpful resource to offer cancer patients -- OralChemoAdvisor.com -- an educational, state-of-the-art Web site about oral chemotherapy. This straightforward, credible site is designed to help cancer patients and their family members make more informed healthcare decisions concerning oral chemotherapy treatment.

"There is a general lack of awareness about oral chemotherapy as a treatment option despite the overwhelming amount of resources dedicated to cancer patients," said Lars E. Birgerson, Vice President of Medical Affairs at Roche, which created and launched the site. "OralChemoAdvisor.com is specifically designed to help patients locate relevant information to help them better understand and assist in managing their treatment."

OralChemoAdvisor.com offers direct and easy access to a variety of educational tools designed to help patients who want to learn more about oral chemotherapy and its efficacy, risks and benefits. The site contains a unique video component that gives patients the option of interacting with oncology medical professionals and helps ensure that new information is retained. The expert videos include guides on oral chemotherapy treatment and patient-doctor communication, both of which also are available in written form. And, OralChemoAdvisor.com offers a list of oral chemotherapy treatments indicated for specific types of cancer, answers to frequently asked questions, and expert insights on cancer management and treatment.

"It is so important for breast cancer patients to have access to the most up-to-date information and resources. Web sites such as oralchemoadvisor.com are an important option for patients to help them make informed decisions about their individual course of treatment," stated Margaret C. Kirk, Chief Executive Officer, Y-ME National Breast Cancer Organization.

According to a recent survey conducted by Manhattan Research, CyberCitizen Health more than 14 million patients and caregivers went online in 2006 to gather information specific to oncology.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News and one of the Top 20 Employers (Science magazine). In 2006, Roche was ranked the No.1 Company to Sell For (Selling Power), and one of AARP's Top Companies for Older Workers, and in 2005, Roche was named one of Fortune magazine's Best Companies to Work For in America. For additional information about the U.S. pharmaceuticals business, visit our websites: http://www.rocheusa.com or http://www.roche.us


'/>"/>
SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Roche offers HIV drug expertise to poor nations
2. Roche Commits More Antiviral Pills To Asia For Bird Flu
3. FDA Imposes New Restrictions On Roches Accutane
4. Roche confirms Tamiflu production talks in US
5. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
6. Roche Rolls Out Lung Cancer Drug In India
7. New Lung Cancer Drug Launched By Roche Pharmaceutical
8. Roche Calls For Re-Examination Of Tarceva Data By EU Authorities
9. Roche puts in an Application to Use Herceptin for Treatment in Her-2 positive breast cancer
10. NICE Gives the Final ‘NO’ to Roche’s Tarcva
11. Roche Announces Major Recall of HIV Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... 06, 2016 , ... From May 4 to 6, EarQ and ... opportunity to learn more about Signia’s technology and the successful business and marketing techniques ... priority to see practices succeed in this highly competitive industry,” said Ed Keller, president ...
(Date:5/6/2016)... Arizona (PRWEB) , ... May 06, 2016 , ... ... moved domains to Sleepopolis.com . , Since launching in September, 2014 Sleepopolis ... research and testing areas, which now include pillows, sheets, mattress toppers, bed frames, ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... online provider of career-focused education and corporate training, and the National Military Family ... to announce Maritza Aquino as the second full-tuition scholarship recipient of 2016. ...
(Date:5/6/2016)... ... May 06, 2016 , ... RowdMap, Inc. ... Cross BlueShield and Former Principal Deputy Administrator at Centers for Medicare and Medicaid ... Steve Ondra, MD, Chief Medical Officer at Health Care Service Corporation (Blue Cross ...
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. , ... a development collaboration with the Australian critical medicine company, Phebra Pty Ltd. ... , LAI medicines can offer improved therapeutic benefits over oral formulations, including better ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 2016 Research and Markets has announced ... in the USA"  report to their offering.  ,     (Logo: ... the current Positron Emission Tomography (PET) scanner and cyclotron ... market. Along with the current known number of PET ... , the report also contains a detailed breakdown of ...
(Date:5/5/2016)... 5, 2016 ... of the  "Europe Thrombocytopenia Market and ... to their offering.       ... ,The latest research Europe Thrombocytopenia Market ... provides comprehensive insights into Thrombocytopenia pipeline ...
(Date:5/4/2016)... Conn., May 4, 2016  Compass Diversified Holdings (NYSE: ... "Company"), an owner of leading middle market businesses, announced ... ended March 31, 2016. First Quarter 2016 ... and Reinvestment ("CAD" or "Cash Flow") of $13.6 million ... net loss of $15.0 million for the first quarter ...
Breaking Medicine Technology: